No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RSLS ReShape Lifesciences
- 0.2050
- -0.0078-3.67%
Trading Jul 24 12:55 ET
4.81MMarket Cap-465P/E (TTM)
0.2211High0.2024Low363.05KVolume0.2100Open0.2128Pre Close77.51KTurnover1.74%Turnover RatioLossP/E (Static)23.46MShares1.510052wk High1.06P/B4.27MFloat Cap0.141452wk Low--Dividend TTM20.84MShs Float80136000.0000Historical High--Div YieldTTM8.79%Amplitude0.1414Historical Low0.2130Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ReShape Lifesciences Inc. Merger
Maxim Group Downgrades ReShape Lifesciences(RSLS.US) to Hold Rating
Express News | Maxim Group Downgrades Reshape Lifesciences to Hold
Reshape Lifesciences Analyst Ratings
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Express News | Vyome Therapeutics : Under Terms, a Newly Formed Wholly Owned Unit of ReShape Will Merge With and Into Vyome
Comments
$ReShape Lifesciences(RSLS.US$ SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ReShape Lifesciences Inc. Merger
newsfile· 22 mins ago![]()
newsfile· 22 mins ago
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys.
On July 10, 2024, ReShape Lifesciences® (Nasdaq: RSLS), a company in weight loss and metabolic health solutions, announced its entry into a definitive merger agreement with Vyome Therapeutics, Inc., a private clinical-stage company focused on immuno-inflammatory and rare diseases. This merger pinpoin...
On July 10, 2024, ReShape Lifesciences® (Nasdaq: RSLS), a company in weight loss and metabolic health solutions, announced its entry into a definitive merger agreement with Vyome Therapeutics, Inc., a private clinical-stage company focused on immuno-inflammatory and rare diseases. This merger pinpoin...
2
$ReShape Lifesciences(RSLS.US$ anyone know what the split will be? and when?
$ReShape Lifesciences(RSLS.US$ Sure hope after merger and the ticker change to HIND causes SS’s to foget how much they love destroying this company??? ![]()
3
$ReShape Lifesciences(RSLS.US$
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape Lifesciences has entered into a merger agreement with Vyome Therapeutics and an asset purchase agreement with Biorad Medisys for $5.16 million.
The all-stock merger will see Vyome and ReShape combine, focusing on immuno-inflammatory diseases. Post-merger, ReShape will be renamed Vyome Holdings and will trade under the Nasdaq ticke...
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape Lifesciences has entered into a merger agreement with Vyome Therapeutics and an asset purchase agreement with Biorad Medisys for $5.16 million.
The all-stock merger will see Vyome and ReShape combine, focusing on immuno-inflammatory diseases. Post-merger, ReShape will be renamed Vyome Holdings and will trade under the Nasdaq ticke...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg